Current cardiac drug safety assessments focus on hERG channel block and QT prolongation for evaluating arrhythmic risks. whereas the optogenetic approach focuses on the action potential (AP) waveform generated by a monolayer of human cardiomyocytes beating synchronously. thus assessing the contribution of several ion channels on the overall drug effect. This novel tool provides arrhyt... https://cxpqlnxjxwvn7.dsiblogger.com/67920580/poly-bis-μ-4-4-carboxyphenoxy-benzoato-μ-4-4-oxydibenzoato-bis-μ-3-pyridin-4-yl-5-pyridin-3-yl-1h-1-2-4-triazole-dicadmium-ii